Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.50 (1.22%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Results

3 Mar 2011 07:00

RNS Number : 2306C
Frontier IP Group plc
03 March 2011
 



FIPP

3 March 2011

 

Frontier IP Group Plc

("Frontier IP", "the Group" or "the Company")

 

Unaudited half year results to 31 December 2010

 

Frontier IP Group plc is focused on the commercialisation of university IP

 

Key Points

 

·; Encouraging results - benefiting from uplift in portfolio valuation

 

·; Total revenue of £296,000 (2009: 6 months £85,000)

 

·; Profit before tax of £69,000 (2009: 6 months loss £97,000)

 

·; Earnings per share of 1.39p (2009: 6 months loss per share 1.96p)*

 

·; Net assets per share as at 31 December 2010 of 50p (31 December 2009: 52p)*

 

·; Cash balances stood at £84,000 as at 31 December 2010 (2009: £469,000)

- raised £1 million (gross) in January 2011

 

·; Foundations for future growth in place:

- post the half year, successful admission to AIM and placing

- strong pipeline of opportunities to expand existing portfolio

- active discussions with additional university partners

 

·; Positive outlook

 

* Calculated using the consolidated number of issued ordinary shares of 10p each of 4,972,165 for all periods

 

 

Neil Crabb, Chairman of Frontier IP, said:

 

"Results for the six months to 31 December 2010 show excellent progress, with Frontier IP moving into profit for the first time. Our portfolio of spin-out companies continues to develop and we have seen an encouraging uplift in the valuation of our holdings.

 

The second half of the current financial year has started well, maintaining the progress achieved in the first half. On 31 January 2011, Frontier IP took a significant step forward with its admission to trading on AIM and at the same time, the completion of a placing to raise £1.0 million (gross) from a number of institutional shareholders.

 

The admission to AIM and placing will support the business as we seek to take advantage of the exciting opportunities available to the Group, both in terms of securing new long-term relationships and developing our existing portfolio.  With the foundations for growth in place, the Board remains confident for the current year and beyond."

 

 

 

 

Enquiries

 

Frontier IP Group plc

Neil Crabb, Chairman

 

T: 0131 220 9491

 

Biddicks

 

Katie Tzouliadis / Sophie Lane

T: 020 3178 6378

Arbuthnot Securities Ltd

Tom Griffiths / Ed Groome

T: 020 7012 2000

 

Company website: www.frontierip.co.uk

Chairman's Statement

 

Introduction

 

I am pleased to present our first set of half year results since Frontier IP was admitted to trading on AIM at the end of January 2011. Results for the six months to 31 December 2010 show excellent progress in the first half, with the Group moving into profit for the first time. This performance was driven in particular by an IFRS uplift in the value of the portfolio and we continue to see good opportunities to expand our existing portfolio as we move through the second half. We have also moved discussions forward with a number of universities regarding potential new relationships during the first half and the pipeline for additional long-term partnerships remains strong.

 

Following the end of the first half, on 31 January 2011, Frontier IP took a significant step in its development by the admission of the Company's shares to trading on AIM and at the same time, undertaking a placing to raise £1.0 million (gross). The AIM quotation will assist the Company in its development and, with a strong financial platform in place to underpin the next growth phase, the Board views prospects very positively.

 

Results

 

Total revenue for the first half of the year was £296,000 (2009: £85,000), comprising anunrealised gain on the revaluation of investments of £218,000 (2009: unrealised loss £4,000) and revenue from services of £78,000 (2009: £89,000). Profit before tax was £69,000 (2009: loss £97,000) and earnings per share was 1.39p (2009: loss per share 1.96p).

 

Cash balances stood at £84,000 as at 31 December 2010 (2009: £469,000). Net assets per share as at 31 December 2010 were 50p (2009: 52p).

 

Following the end of the first half, there was a cash inflow of £1.0 million (gross) by way of a placing of 2,000,000 New Ordinary Shares at 50 pence per share completed on the Company's admission to AIM.

 

Business Model

 

The Frontier IP business model is low cost and offers the potential for high quality earnings and capital appreciation.

 

Our model is to forge close commercialisation relationships with universities and research institutions

whereby, as a result of the assistance provided to these organisations in the commercialisation of the IP produced from their research activities, Frontier IP seeks to share in the founder equity and licence revenue that these organisations receive from the commercialisation of this research. In addition, Frontier IP generates revenue from board retainers and fees for bespoke advisory work. Also, where appropriate, Frontier IP will establish a dedicated fund for each relationship. This will help to accelerate the commercialisation process and will also create recurring fund management income for the Group. Our intention is also to participate as a limited partner in these funds.

 

Our strategy is to grow the portfolio to build a strong foundation of commercialisation relationships, thereby generating value both from recurring revenue and from the capital appreciation of equity in spin-outs and of direct investment in the dedicated funds.

  

Operational Review

 

Frontier IP has taken a number of significant steps forward in its development since the start of the current financial year.

 

Our portfolio of spin-out companies continues to develop and we currently have interests in eight portfolio companies, compared to five at the same point last year. During the first half, we have seen an encouraging uplift in the valuation of our holdings in portfolio companies and we expect to make further progress in adding new companies to our portfolio going forward. We are seeking additional opportunities to expand our funds under management both with dedicated university funds and sector-specific funds, where appropriate.

 

The Group is in active discussions with a number of universities with a view to securing new relationships, which would provide the Group with a share of spin-out equity and licensing revenues on a long-term basis. In addition, Frontier IP intends, where appropriate, to establish dedicated funds for its new partner universities.

 

In September 2010, we strengthened the team with two senior appointments in order to take advantage of the growth opportunities available. Jackie McKay was appointed to the Board as Partnership Director and David Cairns was appointed to the Board as Executive Director. In addition, on admission to AIM, Michael Brennand was appointed Regional Director North West to assist the Group in its regional development. Their combined experience in IP commercialisation underpins our growth plans.

 

The admission to AIM at the end of January 2011 also assists the Company in its development going forward. The enhanced brand and market recognition should help us to secure additional long-term university partners as well as new limited partners for funds. The placing completed at the same time provides Frontier IP with the resources to support new commercialisation relationships, to support complementary advisory roles and capital commitments to new funds.

 

Outlook

 

We are continuing to build on the progress achieved in the first half. Whilst there is considerable disruption in the university sector arising from changes to funding arrangements and general pressure on budgets, demand for our services is increasing as these institutions seek to extract value from their intellectual property. Frontier IP is well placed to take advantage of these market opportunities. We also see the potential for consolidation within the university IP commercialisation sector and the Company's admission to AIM and accompanying placing underpin our aim to participate in this process.

 

With the foundations for growth in place, the Board remains confident for the current year and beyond and I look forward to updating shareholders as the year progresses.

 

Neil Crabb

Chairman

 

2 March 2011

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

For the six months ended 31 December 2010

 

 

 

 

 

Notes

Six months ended31 December

2010 (unaudited)

 Six months ended 31 December

2009 (unaudited)

 

Year ended

 30 June

2010 (audited)

 

£'000

£'000

£'000

Revenue

 

 

 

 

Revenue from services

 

78

89

142

Other operating income

 

 

 

 

Unrealised profit / (loss) on the revaluation of investments

 

218

(4)

(48)

Total revenue

 

296

85

94

 

 

 

 

 

Administrative expenses (net)

 

(227)

(184)

(422)

 

 

 

 

 

Profit / (loss) from operations

 

69

(99)

(328)

 

 

 

 

 

Finance income

 

-

2

2

 

 

 

 

 

Profit / (loss) before tax

 

69

(97)

(326)

 

 

 

 

 

Taxation

5

-

-

-

 

 

 

 

 

Profit / (loss) and total comprehensive income (expense) for the period

 

 

69

 

(97)

 

(326)

 

 

 

 

 

 

 

 

 

 

Earnings /(loss) per share attributable to the equity holders of the Company:

 

 

 

 

Basic earnings / (loss) per share

6

1.39p

(1.96p)

(6.56p)

Diluted earnings / ( loss) per share

6

1.39p

(1.96p)

(6.56p)

 

 

All of the Group's activities are classed as continuing and there were no comprehensive gains or losses in any period other than those included in the statement of comprehensive income.

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

At 31 December 2010

 As at 31 December

2010 (unaudited)

£'000

 As at 31 December

2009 (unaudited)

£'000

As at

30 June

2010 (audited)

£'000

ASSETS

 

 

 

Non-current assets

 

 

 

Goodwill

1,966

1,966

1,966

Financial assets at fair value through profit and loss

461

149

179

2,427

2,115

2,145

Current assets

Trade receivables

Other current assets

Cash and cash equivalents

 

9

45

84

 

48

13

469

 

13

13

330

 

138

530

356

Total assets

2,565

2,645

2,501

 

LIABILITIES

Current liabilities

Trade and other payables

(101)

(54)

(107)

 

Net assets

 

2,464

 

2,591

 

2,394

 

 

EQUITY

Called up share capital

Share premium account

Reverse acquisition reserve

Share based payment reserve

Retained earnings

497

3,898

(1,667)

113

(377)

497

3,898

(1,667)

80

(217)

497

3,898

(1,667)

112

(446)

 

Total equity

 

2,464

 

2,591

 

2,394

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

For the six month period ended 31 December 2010

 

 

 

 

Share

 capital

 

 

Share

premium

account

 

 

Reverse acquisition

 reserve

 

Share-

based

payment

 reserve

 

 

Profit

and loss

account

 

 

 

 

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

At 1st July 2009

497

3,898

(1,667)

78

(120)

2,686

Loss for the period

-

-

-

-

(97)

(97)

Share-based payments

-

-

-

2

-

2

 

At 31 December 2009

497

3,898

(1,667)

80

(217)

2,591

Loss for the period

-

-

-

-

(229)

(229)

Share-based payments

-

-

-

32

-

32

At 30 June 2010

497

3,898

(1,667)

112

(446)

2,394

Profit for the period

-

-

-

-

69

69

Share-based payments

-

-

-

1

-

1

 

At 31 December 2010

497

3,898

(1,667)

113

(377)

2,464

 

 

 

 

 

CONSOLIDATED STATEMENT OF CASH FLOWS

 

For the six months ended 31 December 2010

 

 

Six months ended 31 December

2010 (unaudited)

£'000

 

Six months ended 31 December

2009 (unaudited)

£'000

 

 

Year ended 30 June

2010 (audited)

£'000

Cash flows from operating activities

 

 

 

Cash used in operations

(183)

(129)

(194)

Interest paid

-

-

-

Taxation paid

-

-

-

Net cash used in operating activities

(183)

(129)

(194)

 

 

 

 

Cash flows from investing activities

 

 

 

Purchase of financial assets at fair value through profit and loss

(63)

(114)

(188)

Interest received

-

2

2

 

 

 

 

Net cash used in investing activities

(63)

(112)

(186)

 

 

 

 

Net decrease in cash and cash equivalents

(246)

(241)

(380)

 

 

 

 

Cash and cash equivalents at beginning of period

330

710

710

Cash and cash equivalents at end of period

84

469

330

 

 

 

 

 

 

 

 

Cash used in operations

 

 

 

Profit / (loss) before tax

69

(97)

(326)

Adjustments for share-based payments

1

2

34

Adjustment for finance income

-

(2)

(2)

Fair value (gain)/loss on financial assets at fair value through profit or loss

(218)

4

48

Changes in working capital:

 

 

 

Trade and other receivables

(28)

(44)

(9)

Trade and other payables

(7)

8

61

 

 

 

 

 

(183)

(129)

(194)

 

 

 

 

 

NOTES

 

 

1. General information

The Company is a limited liability company incorporated in England and with its registered office at NorthWest Wing, Bush House, Aldwych, London WC2B 4EZ. The Company's trading office is situated at 41 Charlotte Square, Edinburgh EH2 4HQ.

 

The Company is quoted on AIM after successful admission on 31 January 2011. Prior to this the company was quoted on the PLUS market.

 

This condensed consolidated interim financial information was approved and authorised for issue by a duly appointed and authorised committee of the Board of Directors on 2 March 2011.

 

2. Basis of preparation

This condensed consolidated interim financial information for the six months ended 31 December 2010 has been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting". The condensed consolidated interim financial information should be read in conjunction with the annual financial statements for the year ended 30 June 2010, which have been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the EU.

 

This condensed consolidated interim financial information does not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006. The comparatives for the full year ended 30 June 2010 are not the Company's full statutory accounts for that year. A copy of the statutory accounts for that year has been delivered to the Registrar of Companies. The auditor's report on those accounts was unqualified and did not contain a statement under sections 498(2) or 498(3) of the Companies Act 2006.

3. Accounting policies

The accounting policies applied are consistent with those of the annual financial statements for the year ended 30 June 2010 as described in the Group's Annual Report for that year and as available on our website www.frontierip.co.uk.

 

Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual earnings.

 

4. Segmental information

The chief operating decision-maker has been identified as the Group board of directors. The board reviews the Group's internal reporting in order to assess performance and allocate resources. Currently the Group has one operating activity, the commercialisation of University IP. All of the Group's activities are carried out in the UK.

 

5. Taxation

There is no charge to taxation for the six months to 31 December 2010 (2009: Nil). Although the Group made a profit for the period, it made a taxable loss after adjustment for non-taxable income.

 

A deferred tax asset has not been recognised in respect of losses in view of the uncertainty as to the level of future taxable profits.

 

 

6. Earnings / (loss) per share

The calculation of the basic earnings/(loss) per share for the six months ended 31 December 2010 and 31 December 2009 and for the year ended 30 June 2010 is based on the profits/(losses) attributable to the shareholders of Frontier IP Group Plc in each period divided by the weighted average number of shares in issue during the period.

 

A resolution to consolidate the share capital of the Company by issuing one new Ordinary share of 10p each for every 100 Ordinary shares of 0.1p each was passed at the Company's Annual General Meeting on 6 December 2010. The earnings and loss per share have been calculated as though the consolidation occurred on 30 June 2009.

 

 

 

Profits/(losses) attributable to shareholders

Weighted average number of shares

Basic earnings/ (loss) per share

 

£'000

Number

Pence

 

 

 

 

Six months ended 31 December 2010

69

4,972,165

1.39

Six months ended 31 December 2009

(97)

4,972,165

(1.96)

Year ended 30 June 2010

(326)

4,972,165

(6.56)

 

No warrant or option is potentially dilutive as the average market price of the ordinary shares during the above periods was less than the exercise price of the warrants and options, hence basic and diluted loss per share are the same.

 

7. Copies of Half Yearly Report

Copies of this announcement are available on the Company's website, www.frontierip.co.uk, and copies of the Half Yearly Report will be sent to shareholders and will be available on the Company's website and on request from the Company's offices at 41 Charlotte Square, Edinburgh EH2 4HQ no later than 31 March 2011.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFSDVVIFIIL
Date   Source Headline
7th May 202410:15 amRNSTVG to collaborate with The Pirbright Institute
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.